TABLE 1.
Country | Year(s) | Genogroup(s)a | No. of isolates testedb |
---|---|---|---|
Argentina | 1998 | 4b | 1 |
Australia | 1956–1997 | 1, 2, 3, 4a, 4b | 20 |
Canada | 1985–1997 | 4a, 4b | 15 |
Chile | 1993–1994 | 4b | 2 |
Colombia | 1994–1995 | 1, 4b | 2 |
Germany | 1988–1996 | 4b | 3 |
Israel | 1999 | 1, 4b | 9 |
Kuwait | 1999 | 4b | 2 |
Mexico | 1992 | 4b | 1 |
The Netherlands | 1999 | 1 | 4 |
Philippines | 1995 | Not assigned | 1 |
Poland | 1999 | 4b | 4 |
Puerto Rico | 1961 | 1 | 1 |
Trinidad and Tobago | 1983 | 4a | 1 |
Tunisia | 1998–1999 | 4b | 2 |
Turkey | 1999 | 4b | 2 |
United Kingdom | 1959 | 2 | 1 |
United States | 1957–1998 | 1, 2, 3, 4a, 4b | 150 |
Total | 1956–1999 | 1, 2, 3, 4a, 4b | 221 |
E30 genogroups are those described previously (20).
The 158-bp E30-specific product was amplified from all E30 isolates tested.